In Merck’s case, worries over rising competition from so-called ‘biosimilar’ generic products, which approximate the biological chemical structure of branded medicines, is behind much of the ...

EAU CLAIRE (WQOW) - The Eau Claire Police Department is investigating a weekend drowning at Half Moon Lake. According to ...

North Branch Land Trust invites nature-lovers, conservationists and families to attend our Paddle and Pour event. From 11 a.m. to 1 p.m. Saturday, June 21, participants will have an introductory ...

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

Martini started helping people in 2004 after Hurricane Charley hit Florida. But more than 20 years later, what began as ...

MoonLake jumps 18% after a report says MRK made a $3 billion-plus offer earlier this year, with talks potentially set to resume.

MoonLake’s stock rocketed 20% after reports claimed Merck made a $3 billion acquisition offer to boost its drug pipeline.

Stocks closed higher on Tuesday as the Nasdaq Composite finished the day higher for the year even as uncertainty over global ...

MoonLake Immunotherapeutics' Sonelokimab's Phase 3 trials, PsA market growth, and Merck's $3B bid showcase potential. Read my ...

Merck submitted a nonbinding offer for the smaller biotech earlier in the year, according to a media report citing people ...

Barreling toward the loss of exclusivity on its blockbuster oncology therapy Keytruda, Merck & Co. has reportedly offered $3 ...

Merck reportedly offered over $3 billion for MoonLake Immunotherapeutics, targeting its late-stage inflammatory drug as it ...